Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
73
AKRO
Akero Therapeutics
Last Price:
28.07
Seasonality Move:
-3.65%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.89 | Buy |
20-day SMA: | 26.7 | Buy |
50-day SMA: | 26.3 | Buy |
200-day SMA: | 23.5 | Buy |
8-day EMA: | 27.15 | Buy |
20-day EMA: | 26.65 | Buy |
50-day EMA: | 25.83 | Buy |
200-day EMA: | 25.59 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 62.09 | Buy |
Chaikin Money Flow: | 623991 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.82 - 27.3) | Buy |
Bollinger Bands (100): | (21.03 - 26.75) | Buy |
Akero Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 28.07 while AKRO 8-day simple moving average is 26.89, which is a Buy signal.
- The stock price of AKRO is 28.07 while Akero Therapeutics 20-day SMA is 26.70, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 26.30 while AKRO share price is 28.07, making it a Buy technically.
- AKRO stock price is 28.07 and Akero Therapeutics 200-day simple moving average is 23.50, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
73
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $28.07. The Score for AKRO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.95B
Price in USD:
28.07
Share Volume:
705.03K
Akero Therapeutics 52-Week Range
52-Week High:
51.24
52-Week Low:
11.25
Buy
73
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 28.07 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 28.07 while AKRO 8-day exponential moving average is 27.15, which is a Buy signal.
- The stock price of AKRO is 28.07 while Akero Therapeutics 20-day EMA is 26.65, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 25.83 while AKRO share price is 28.07, making it a Buy technically.
- AKRO stock price is 28.07 and Akero Therapeutics 200-day simple moving average is 25.59, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.45, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 62.09, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (25.82 - 27.3), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (21.03 - 26.75), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.